There are many challenges in developing efficient and target specific delivery systems of small molecule and nucleic acid drugs. Cell membrane presents one of the major barriers for the penetration of hydrophilic macromolecules across the plasma membrane. Nanocarriers have been designed to enhance their cellular uptake via endocytosis but following their cellular uptake, endosomal escape is the rate limiting step which restricts the value associated with the enhanced uptake by nanocarriers. Viruses are an excellent model for efficient cytosolic delivery by nanocarriers. Viruses exploit intracellular cues to release the genome to cytosol. In this review, we first discuss different endocytic uptake pathways and endosomal escape mechanisms. We then summarize the existing tools for studying the intracellular trafficking of nanocarriers. Finally, we highlight the important design elements of recent virus-based nanocarriers for efficient cellular uptake and endosomal escape.
蒙德拉. 设计高效细胞吸收的携带者和内释放小分子和核酸药物:学习病毒[J]. Frontiers of Chemical Science and Engineering, 2014, 8(4): 387-404.
Vaibhav Mundra, Ram I. Mahato. Design of nanocarriers for efficient cellular uptake and endosomal release of small molecule and nucleic acid drugs: learning from virus. Front. Chem. Sci. Eng., 2014, 8(4): 387-404.
Petros R A, DeSimone J M. Strategies in the design of nanoparticles for therapeutic applications. Nature Reviews. Drug Discovery, 2010, 9(8): 615–627
2
Kim S, Kim J H, Jeon O, Kwon I C, Park K. Engineered polymers for advanced drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 2009, 71(3): 420–430
3
Mahato R I, Rolland A, Tomlinson E. Cationic lipid-based gene delivery systems: Pharmaceutical perspectives. Pharmaceutical Research, 1997, 14(7): 853–859
4
Mahato R I. Water insoluble and soluble lipids for gene delivery. Advanced Drug Delivery Reviews, 2005, 57(5): 699–712
5
Al-Dosari M S, Gao X. Nonviral gene delivery: Principle, limitations, and recent progress. The AAPS Journal, 2009, 11(4): 671–681
6
Mahato R I, Takakura Y, Hashida M. Nonviral vectors for in vivo gene delivery: Physicochemical and pharmacokinetic considerations. Critical Reviews in Therapeutic Drug Carrier Systems, 1997, 14(2): 133–172
7
Mudhakir D, Harashima H. Learning from the viral journey: How to enter cells and how to overcome intracellular barriers to reach the nucleus. The AAPS Journal, 2009, 11(1): 65–77
8
Singer S J, Nicolson G L. The fluid mosaic model of the structure of cell membranes. Science, 1972, 175(4023): 720–731
9
Camenisch G, Alsenz J, van de Waterbeemd H, Folkers G. Estimation of permeability by passive diffusion through caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. European Journal of Pharmaceutical Sciences, 1998, 6(4): 317–324
10
Hsu V W, Bai M, Li J. Getting active: Protein sorting in endocytic recycling. Nature Reviews. Molecular Cell Biology, 2012, 13(5): 323–328
11
Babst M. MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between. Current Opinion in Cell Biology, 2011, 23(4): 452–457
12
Hatakeyama H, Akita H, Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma. Advanced Drug Delivery Reviews, 2011, 63(3): 152–160
13
Rejman J, Oberle V, Zuhorn I S, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. The Biochemical Journal, 2004, 377(Pt 1): 159–169
14
Wang J, Li L, Zhou Y. Creep effect on cellular uptake of viral particles. Chinese Science Bulletin, 2014, 59(19): 2277–2281
15
Mercer J, Schelhaas M, Helenius A. Virus entry by endocytosis. Annual Review of Biochemistry, 2010, 79: 803–833
16
McMahon H T, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nature Reviews. Molecular Cell Biology, 2011, 12(8): 517–533
17
Doherty G J, McMahon H T. Mechanisms of endocytosis. Annual Review of Biochemistry, 2009, 78: 857–902
18
Harush-Frenkel O, Debotton N, Benita S, Altschuler Y. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochemical and Biophysical Research Communications, 2007, 353(1): 26–32
19
Rejman J, Bragonzi A, Conese M. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Molecular Therapy, 2005, 12(3): 468–474
20
van der Aa M A, Huth U S, H?fele S Y, Schubert R, Oosting R S, Mastrobattista E, Hennink W E, Peschka-Süss R, Koning G A, Crommelin D J. Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharmaceutical Research, 2007, 24(8): 1590–1598
21
Le P U, Guay G, Altschuler Y, Nabi I R. Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. The Journal of Biological Chemistry, 2002, 277(5): 3371–3379
22
Sahay G, Alakhova D Y, Kabanov A V. Endocytosis of nanomedicines. Journal of Controlled Release, 2010, 145(3): 182–195
23
Pelkmans L, Helenius A. Endocytosis via caveolae. Traffic, 2002, 3(5): 311–320
24
Parton R G, Howes M T. Revisiting caveolin trafficking: The end of the caveosome. The Journal of Cell Biology, 2010, 191(3): 439–441
25
Raghava S, Giorda K M, Romano F B, Heuck A P, Hebert D N. SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral release. Biochemistry, 2013, 52(22): 3939–3948
26
Damm E M, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A. Clathrin- and caveolin-1-independent endocytosis: Entry of simian virus 40 into cells devoid of caveolae. The Journal of Cell Biology, 2005, 168(3): 477–488
27
Kirkham M, Fujita A, Chadda R, Nixon S J, Kurzchalia T V, Sharma D K, Pagano R E, Hancock J F, Mayor S, Parton R G. Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. The Journal of Cell Biology, 2005, 168(3): 465–476
28
Mercer J, Helenius A. Gulping rather than sipping: Macropinocytosis as a way of virus entry. Current Opinion in Microbiology, 2012, 15(4): 490–499
29
Mercer J, Helenius A. Virus entry by macropinocytosis. Nature Cell Biology, 2009, 11(5): 510–520
30
Hewlett L J, Prescott A R, Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. The Journal of Cell Biology, 1994, 124(5): 689–703
31
Kerr M C, Lindsay M R, Luetterforst R, Hamilton N, Simpson F, Parton R G, Gleeson P A, Teasdale R D. Visualisation of macropinosome maturation by the recruitment of sorting nexins. Journal of Cell Science, 2006, 119(Pt 19): 3967–3980
32
Meier O, Boucke K, Hammer S V, Keller S, Stidwill R P, Hemmi S, Greber U F. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. The Journal of Cell Biology, 2002, 158(6): 1119–1131
33
Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda S M, Muzykantov V R, Koval M. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. Journal of Cell Science, 2003, 116(Pt 8): 1599–1609
34
Dausend J, Musyanovych A, Dass M, Walther P, Schrezenmeier H, Landfester K, Mailander V. Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromolecular Bioscience, 2008, 8(12): 1135–1143
35
Youm I, Bazzil J D, Otto J W, Caruso A N, Murowchick J B, Youan B B. Influence of surface chemistry on cytotoxicity and cellular uptake of nanocapsules in breast cancer and phagocytic cells. The AAPS Journal, 2014, 16(3): 550–567
36
Agarwal R, Singh V, Jurney P, Shi L, Sreenivasan S V, Roy K. Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110(43): 17247–17252
37
Fernando L P, Kandel P K, Yu J, McNeill J, Ackroyd P C, Christensen K A. Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles. Biomacromolecules, 2010, 11(10): 2675–2682
38
Meng H, Yang S, Li Z, Xia T, Chen J, Ji Z, Zhang H, Wang X, Lin S, Huang C, Zhou Z H, Zink J I, Nel A E. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano, 2011, 5(6): 4434–4447
39
Sahay G, Querbes W, Alabi C, Eltoukhy A, Sarkar S, Zurenko C, Karaqiannis E, Love K, Chen D, Zoncu R, Buqanin Y, Schroeder A, Langer R, Anderson D G. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nature Biotechnology, 2013, 31(7): 653–658
40
Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, St?ter M, Epstein-Barash H, Zhang L, Koteliansky V, Fitzqerald K, Fava E, Bickle M, Kalaidzidis Y, Akinc A, Maier M, Zerial M. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nature Biotechnology, 2013, 31(7): 638–646
41
Kirkham M, Parton R G. Clathrin-independent endocytosis: New insights into caveolae and non-caveolar lipid raft carriers. Biochimica Et Biophysica Acta, 2005, 1745(3): 273–286
42
Grassart A, Dujeancourt A, Lazarow P B, Dautry-Varsat A, Sauvonnet N. Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2. EMBO Reports, 2008, 9(4): 356–362
43
Kumari S, Mayor S. ARF1 is directly involved in dynamin-independent endocytosis. Nature Cell Biology, 2008, 10(1): 30–41
44
Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Advanced Drug Delivery Reviews, 2004, 56(8): 1099–1109
45
Wang Y, Huang L. A window onto siRNA delivery. Nature Biotechnology, 2013, 31(7): 611–612
46
Sakai-Kato K, Un K, Nanjo K, Nishiyama N, Kusuhara H, Kataoka K, Kawanishi T, Goda Y, Okuda H. Elucidating the molecular mechanism for the intracellular trafficking and fate of block copolymer micelles and their components. Biomaterials, 2014, 35(5): 1347–1358
47
Ohno S, Takanashi M, Sudo K, Uedo S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Molecular Therapy, 2013, 21(1): 185–191
48
Meier O, Greber U F. Adenovirus endocytosis. The Journal of Gene Medicine, 2003, 5(6): 451–462
49
Zaitseva E, Yang S T, Melikov K, Pourmal S, Chernomordik L V. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathogens, 2010, 6(10): e1001131
50
Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. Role of endosomal cathepsins in entry mediated by the ebola virus glycoprotein. Journal of Virology, 2006, 80(8): 4174–4178
51
Kielian M, Rey F A. Virus membrane-fusion proteins: More than one way to make a hairpin. Nature Reviews. Microbiology, 2006, 4(1): 67–76
52
Dimitrov D S. Virus entry: Molecular mechanisms and biomedical applications. Nature Reviews. Microbiology, 2004, 2(2): 109–122
53
Earp L J, Delos S E, Park H E, White J M. The many mechanisms of viral membrane fusion proteins. Current Topics in Microbiology and Immunology, 2005, 285: 25–66
54
Han X, Bushweller J H, Cafiso D S, Tamm L K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nature Structural Biology, 2001, 8(8): 715–720
55
Semple S C, Akinc A, Chen J, Sandhu A P, Mui B L, Cho C K, Sah D W, Stebbing D, Crosley E J, Yaworski E, Hafez I M, Dorkin J R, Qin J, Lam K, Rajeev K G, Wong K F, Jeffs L B, Nechev L, Eisenhardt M L, Jayaraman M, Kazem M, Maier M A, Srinivasulu M, Weinstein M J, Chen Q, Alvarez R, Barros S A, De S, Klimuk S K, Borland T, Kosovrasti V, Cantley W L, Tam Y K, Manoharan M, Ciufolini M A, Tracy M A, de Fougerolles A, MacLachlan I, Cullis P R, Madden T D, Hope M J. Rational design of cationic lipids for siRNA delivery. Nature Biotechnology, 2010, 28(2): 172–176
56
Felgner J H, Kumar R, Sridhar C N, Wheeler C J, Tsai Y J, Border R, Ramsey P, Martin M, Felgner P L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. The Journal of Biological Chemistry, 1994, 269(4): 2550–2561
57
Pack D W, Hoffman A S, Pun S, Stayton P S. Design and development of polymers for gene delivery. Nature Reviews. Drug Discovery, 2005, 4(7): 581–593
58
Midoux P, Pichon C, Yaouanc J J, Jaffres P A. Chemical vectors for gene delivery: A current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. British Journal of Pharmacology, 2009, 157(2): 166–178
59
Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochimica Et Biophysica Acta, 1999, 1462(1–2): 55–70
60
Mahat R I, Monera O D, Smith L C, Rolland A. Peptide-based gene delivery. Current Opinion in Molecular Therapeutics, 1999, 1(2): 226–243
61
Prchla E, Plank C, Wagner E, Blaas D, Fuchs R. Virus-mediated release of endosomal content in vitro: Different behavior of adenovirus and rhinovirus serotype 2. The Journal of Cell Biology, 1995, 131(1): 111–123
62
Brabec M, Schober D, Wagner E, Bayer N, Murphy R F, Blaas D, Fuchs R. Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis. Journal of Virology, 2005, 79(2): 1008–1016
63
Suikkanen S, Antila M, Jaatinen A, Vihinen-Ranta M, Vuento M. Release of canine parvovirus from endocytic vesicles. Virology, 2003, 316(2): 267–280
64
Farr G A, Zhang L G, Tattersall P. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(47): 17148–17153
65
Kamper N, Day P M, Nowak T, Selinka H C, Florin L, Bolscher J, Hilbig L, Schiller J T, Sapp M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. Journal of Virology, 2006, 80(2): 759–768
66
Wiethoff C M, Wodrich H, Gerace L, Nemerow G R. Adenovirus protein VI mediates membrane disruption following capsid disassembly. Journal of Virology, 2005, 79(4): 1992–2000
67
Zhao H, Yung L Y. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting. Journal of Biomedical Materials Research. Part A, 2009, 91(2): 505–518
68
Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, Jiang X. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Scientific Reports, 2013, 3: 2534
69
Chen H, Kim S, Li L, Wang S, Park K, Cheng J X. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by forster resonance energy transfer imaging. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(18): 6596–6601
70
Xu P, Gullotti E, Tong L, Highley C B, Errabelli D R, Hasan T, Cheng J X, Kohane D S, Yeo Y. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Molecular Pharmaceutics, 2009, 6(1): 190–201
71
Chen H, Kim S, He W, Wang H, Low P S, Park K, Cheng J X. Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir, 2008, 24(10): 5213–5217
72
Nuutila J, Lilius E M. Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytometry. Part A : The Journal of the International Society for Analytical Cytology, 2005, 65(2): 93–102
73
Haas B L, Matson J S, DiRita V J, Biteen J S. Imaging live cells at the nanometer-scale with single-molecule microscopy: Obstacles and achievements in experiment optimization for microbiology. Molecules, 2014, 19(8): 12116–12149
74
Muller B, Heilemann M. Shedding new light on viruses: Super-resolution microscopy for studying human immunodeficiency virus. Trends in Microbiology, 2013, 21(10): 522–533
75
Grove J. Super-resolution microscopy: A virus’ eye view of the cell. Viruses, 2014, 6(3): 1365–1378
76
Perez-Jimenez R, Alonso-Caballero A, Berkovich R, Franco D, Chen M W, Richard P, Badilla C L, Fernandez J M. Probing the effect of force on HIV-1 receptor CD4. ACS Nano, 2014, 8(10): 10313–10320
77
Welsher K, Yang H. Multi-resolution 3D visualization of the early stages of cellular uptake of peptide-coated nanoparticles. Nature Nanotechnology, 2014, 9(3): 198–203
78
Sahay G, Batrakova E V, Kabanov A V. Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport. Bioconjugate Chemistry, 2008, 19(10): 2023–2029
79
dos Santos T, Varela J, Lynch I, Salvati A, Dawson K A. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PloS ONE, 2011, 6(9): e24438
80
Ivanov A I. Pharmacological inhibition of endocytic pathways: Is it specific enough to be useful? Methods in Molecular Biology, 2008, 440: 15–33
81
Payne C K, Jones S A, Chen C, Zhuang X. Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic, 2007, 8(4): 389–401
82
Torgersen M L, Skretting G, van Deurs B, Sandvig K. Internalization of cholera toxin by different endocytic mechanisms. Journal of Cell Science, 2001, 114(Pt 20): 3737–3747
83
Massol R H, Larsen J E, Fujinaga Y, Lencer W I, Kirchhausen T. Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways. Molecular Biology of the Cell, 2004, 15(8): 3631–3641
84
Rupper A, Lee K, Knecht D, Cardelli J. Sequential activities of phosphoinositide 3-kinase, PKB/aakt, and Rab7 during macropinosome formation in dictyostelium. Molecular Biology of the Cell, 2001, 12(9): 2813–2824
85
Rappoport J Z, Simon S M. A functional GFP fusion for imaging clathrin-mediated endocytosis. Traffic, 2008, 9(8): 1250–1255
86
Greber U F, Willetts M, Webster P, Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell, 1993, 75(3): 477–486
87
Colin M, Maurice M, Trugnan G, Kornprobst M, Harbottle R P, Knight A, Cooper R G, Miller A D, Capeau J, Coutelle C, Brahimi-Horn M C. Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Therapy, 2000, 7(2): 139–152
88
Drose S, Altendorf K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. The Journal of Experimental Biology, 1997, 200(Pt 1): 1–8
89
van Rossenberg S M, Sliedregt-Bol K M, Meeuwenoord N J, van Berkel T J, van Boom J H, van der Marel G A, Biessen E A. Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery. The Journal of Biological Chemistry, 2002, 277(48): 45803–45810
90
Mastrobattista E, Koning G A, van Bloois L, Filipe A C, Jiskoot W, Storm G. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. The Journal of Biological Chemistry, 2002, 277(30): 27135–27143
91
Boeneman K, Delehanty J B, Blanco-Canosa J B, Susumu K, Stewart M H, Oh E, Huston A L, Dawson G, Ingale S, Walters R, Domowicz M, Deschamps J R, Algar W R, Dimaggio S, Manono J, Spillmann C M, Thompson D, Jennings T L, Dawson P E, Medintz I L. Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials. ACS Nano, 2013, 7(5): 3778–3796
92
El-Sayed A, Khalil I A, Kogure K, Futaki S, Harashima H. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. The Journal of Biological Chemistry, 2008, 283(34): 23450–23461
93
Alabi C A, Sahay G, Langer R, Anderson D G. Development of siRNA-probes for studying intracellular trafficking of siRNA nanoparticles. Integrative Biology: Quantitative Biosciences from Nano to Macro, 2013, 5(1): 224–230
94
Hama S, Akita H, Ito R, Mizuguchi H, Hayakawa T, Harashima H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Molecular Therapy, 2006, 13(4): 786–794
95
Mishra S, Webster P, Davis M E. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. European Journal of Cell Biology, 2004, 83(3): 97–111
96
Ma Y, Nolte R J, Cornelissen J J. Virus-based nanocarriers for drug delivery. Advanced Drug Delivery Reviews, 2012, 64(9): 811–825
97
Galdiero S, Vitiello M, Falanga A, Cantisani M, Incoronato N, Galdiero M. Intracellular delivery: Exploiting viral membranotropic peptides. Current Drug Metabolism, 2012, 13(1): 93–104
98
Berry C C. Intracellular delivery of nanoparticles via the HIV-1 tat peptide. Nanomedicine, 2008, 3(3): 357–365
99
Chugh A, Eudes F, Shim Y S. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells. IUBMB Life, 2010, 62(3): 183–193
100
Schwarze S R, Ho A, Vocero-Akbani A, Dowdy S F. In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science, 1999, 285(5433): 1569–1572
101
Torchilin V P, Levchenko T S, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B, D’Souza G G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(4): 1972–1977
102
Mitchell D J, Kim D T, Steinman L, Fathman C G, Rothbard J B. Polyarginine enters cells more efficiently than other polycationic homopolymers. The Journal of Peptide Research, 2000, 56(5): 318–325
103
Ludtke J J, Zhang G, Sebestyen M G, Wolff J A. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. Journal of Cell Science, 1999, 112(Pt 12): 2033–2041
104
Chen F, Gerion D. Fluorescent CdSe/ZnS Nanocrystal peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Letters, 2004, 4(10): 1827–1832
105
Kang M J, Park S H, Kang M H, Park M J, Choi Y W. Folic acid-tethered pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: Conformational characterization and in vitro cellular uptake evaluation. International Journal of Nanomedicine, 2013, 8: 1155–1165
106
Hatakeyama H, Ito E, Akita H, Oishi M, Nagasaki Y, Futaki S, Harashima H. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. Journal of Controlled Release, 2009, 139(2): 127–132
107
Milletti F. Cell-penetrating peptides: Classes, origin, and current landscape. Drug Discovery Today, 2012, 17(15–16): 850–860
108
Bartz R, Fan H, Zhang J, Innocent N, Cherrin C, Beck S C, Pei Y, Momose A, Jadhav V, Tellers D M, Meng F, Crocker L S, Sepp-Lorenzino L, Barnett S F. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. The Biochemical Journal, 2011, 435(2): 475–487
109
Li W, Nicol F, Szoka F C, Jr. GALA: A designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Advanced Drug Delivery Reviews, 2004, 56(7): 967–985
110
Wadia J S, Stan R V, Dowdy S F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature Medicine, 2004, 10(3): 310–315
111
Funhoff A M, van Nostrum C F, Lok M C, Fretz M M, Crommelin D J, Hennink W E. Poly(3-guanidinopropyl methacrylate): A novel cationic polymer for gene delivery. Bioconjugate Chemistry, 2004, 15(6): 1212–1220
112
Oliveira S, van Rooy I, Kranenburg O, Storm G, Schiffelers R M. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. International Journal of Pharmaceutics, 2007, 331(2): 211–214
113
Kwon E J, Bergen J M, Pun S H. Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjugate Chemistry, 2008, 19(4): 920–927
114
Aoyama Y, Kanamori T, Nakai T, Sasaki T, Horiuchi S, Sando S, Niidome T. Artificial viruses and their application to gene delivery. Size-controlled gene coating with glycocluster nanoparticles. Journal of the American Chemical Society, 2003, 125(12): 3455–3457
115
Schatz C, Louguet S, le Meins J F, Lecommandoux S. Polysaccharide-block-polypeptide copolymer vesicles: Towards synthetic viral capsids. Angewandte Chemie (International ed. in English), 2009, 48(14): 2572–2575
116
Bui L, Abbou S, Ibarboure E, Guidolin N, Staedel C, Toulme J J, Lecommandoux S, Schatz C. Encapsidation of RNA-polyelectrolyte complexes with amphiphilic block copolymers: Toward a new self-assembly route. Journal of the American Chemical Society, 2012, 134(49): 20189–20196
117
Muller K, Nahde T, Fahr A, Muller R, Brusselbach S. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Therapy, 2001, 8(2): 107–117
118
Wu D T, Roth M J. MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors. Biomaterials, 2014, 35(29): 8416–8426
119
Keswani R K, Pozdol I M, Pack D W. Design of hybrid lipid/retroviral-like particle gene delivery vectors. Molecular Pharmaceutics, 2013, 10(5): 1725–1735
120
de la Escosura A, Janssen P G, Schenning A P, Nolte R J, Cornelissen J J. Encapsulation of DNA-templated chromophore assemblies within virus protein nanotubes. Angewandte Chemie (International ed. in English), 2010, 49(31): 5335–5338
121
Ruff Y, Moyer T, Newcomb C J, Demeler B, Stupp S I. Precision templating with DNA of a virus-like particle with peptide nanostructures. Journal of the American Chemical Society, 2013, 135(16): 6211–6219
122
Li F, Chen Y, Chen H, He W, Zhang Z P, Zhang X E, Wang Q. Monofunctionalization of protein nanocages. Journal of the American Chemical Society, 2011, 133(50): 20040–20043
123
Murthy N, Robichaud J R, Tirrell D A, Stayton P S, Hoffman A S. The design and synthesis of polymers for eukaryotic membrane disruption. Journal of Controlled Release, 1999, 61(1–2): 137–143
124
Shima F, Akagi T, Akashi M. Synthesis and preparation of nanoparticles composed of amphiphilic poly(I^3<?Pub Caret?><?A3B2 h=-0.3h?>-glutamic acid) with different hydrophobic side chains and their potential of membrane disruptive activity. Colloid and Polymer Science, 2014, 292(10): 2663–2671
125
Lin Y L, Jiang G, Birrell L K, El-Sayed M E. Degradable, pH-sensitive, membrane-destabilizing, comb-like polymers for intracellular delivery of nucleic acids. Biomaterials, 2010, 31(27): 7150–7166
126
Liu Q, Chen J, Du J. Asymmetrical polymer vesicles with a “stealthy” outer corona and an endosomal-escape-accelerating inner corona for efficient intracellular anticancer drug delivery. Biomacromolecules, 2014, 15(8): 3072–3082
127
Buerkli C, Lee S H, Moroz E, Stuparu M C, Leroux J C, Khan A. Amphipathic homopolymers for siRNA delivery: Probing impact of bifunctional polymer composition on transfection. Biomacromolecules, 2014, 15(5): 1707–1715
128
Shima F, Akagi T, Uto T, Akashi M. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(gamma-glutamic acid) nanoparticles. Biomaterials, 2013, 34(37): 9709–9716
129
Henry S M, El-Sayed M E, Pirie C M, Hoffman A S, Stayton P S. pH-responsive poly(styrene-alt-maleic anhydride) alkylamide copolymers for intracellular drug delivery. Biomacromolecules, 2006, 7(8): 2407–2414
130
Convertine A J, Diab C, Prieve M, Paschal A, Hoffman A S, Johnson P H, Stayton P S. pH-responsive polymeric micelle carriers for siRNA drugs. Biomacromolecules, 2010, 11(11): 2904–2911
131
Gu W, Jia Z, Truong N P, Prasadam I, Xiao Y, Monteiro M J. Polymer nanocarrier system for endosome escape and timed release of siRNA with complete gene silencing and cell death in cancer cells. Biomacromolecules, 2013, 14(10): 3386–3389
132
Petersen J, Dandri M, Mier W, Lütgehetmann M, Volz T, von Weizs?cker F, Haberkorn U, Fischer L, Pollok J M, Erbes B, Seitz S, Urban S. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nature Biotechnology, 2008, 26(3): 335–341
133
Zhang X, Zhang Q, Peng Q, Zhou J, Liao L, Sun X, Zhang L, Gong T. Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells. Biomaterials, 2014, 35(23): 6130–6141
134
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology, 2011, 29(4): 341–345
135
Hwang do W, Son S, Jang J, Youn H, Lee S, Lee D, Lee Y S, Jeong J M, Kim W J, Lee D S. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials, 2011, 32(21): 4968–4975